BACKGROUND AND PURPOSE: The guided angiography system, an integrated angiography system, enables continuous guidance and flushing during diagnostic procedures. A guidewire provides guidance by remaining inside the catheter during contrast injection into tortuous vessels. While its feasibility was demonstrated in a retrospective study, this randomized controlled trial aims to evaluate its safety and effectiveness. MATERIALS AND METHODS: This single-center, single-blind, randomized controlled trial was conducted from September 2021 to June 2022. Patients with unruptured intracranial aneurysms were enrolled and randomly assigned to either the guided or the conventional group. Primary outcomes were procedure time and serious adverse events. Secondary outcomes included catheterization success, adverse events, fluoroscopy time, fluoroscopy dose, and image quality. RESULTS: A total of 200 participants (mean age 59 ± 10 years, 71% women) were randomized into the guided (n = 100) and the conventional (n = 100) groups. The guided group demonstrated shorter procedure times compared to the conventional group (18.3 ±9.2 min vs. 21.3 ± 8.1 min, CONCLUSIONS: The guided angiography system offers a simple and effective alternative for diagnostic cerebral catheter angiography, with reduced radiation exposure and a favorable safety profile. ABBREVIATIONS: AE = adverse events
Fr = French.